SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009838
Filing Date
2023-05-15
Accepted
2023-05-15 16:03:12
Documents
103
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gdnsf-20230331x10q.htm   iXBRL 10-Q 1307254
2 EX-4.7 gdnsf-20230331xex4d7.htm EX-4.7 194414
3 EX-10.45 gdnsf-20230331xex10d45.htm EX-10.45 1449532
4 EX-31.1 gdnsf-20230331xex31d1.htm EX-31.1 15601
5 EX-31.2 gdnsf-20230331xex31d2.htm EX-31.2 14091
6 EX-32.1 gdnsf-20230331xex32d1.htm EX-32.1 8602
  Complete submission text file 0001558370-23-009838.txt   9430913

Data Files

Seq Description Document Type Size
7 EX-101.SCH gdnsf-20230331.xsd EX-101.SCH 73867
8 EX-101.CAL gdnsf-20230331_cal.xml EX-101.CAL 77734
9 EX-101.DEF gdnsf-20230331_def.xml EX-101.DEF 232124
10 EX-101.LAB gdnsf-20230331_lab.xml EX-101.LAB 545503
11 EX-101.PRE gdnsf-20230331_pre.xml EX-101.PRE 431865
97 EXTRACTED XBRL INSTANCE DOCUMENT gdnsf-20230331x10q_htm.xml XML 1358040
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Goodness Growth Holdings, Inc. (Filer) CIK: 0001771706 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56225 | Film No.: 23921865
SIC: 2834 Pharmaceutical Preparations